Filter Results
:
(114)
Show Results For
-
All HBS Web
(484)
- Faculty Publications (114)
Show Results For
-
All HBS Web
(484)
- Faculty Publications (114)
←
Page 6 of
114
Results
- July 2009 (Revised May 2010)
- Case
Pfizer: Letter from the Chairman (A)
By: Robert L. Simons and Natalie Kindred
This case explores maximizing shareholder value as a goal in executive decision making. Over a period of nine years, three different Pfizer CEOs make critical decisions intended to increase shareholder value. But the results are disappointing. To allow students to...
View Details
Keywords:
Decision Choices and Conditions;
Corporate Accountability;
Corporate Governance;
Annual Reports;
Business and Shareholder Relations;
Value Creation;
Pharmaceutical Industry;
United States
Simons, Robert L., and Natalie Kindred. "Pfizer: Letter from the Chairman (A)." Harvard Business School Case 110-003, July 2009. (Revised May 2010.)
- January 2009 (Revised February 2009)
- Case
Sydney IVF: Stem Cell Research
By: Robert L. Simons, Kathryn Rosenberg and Natalie Kindred
This case examines the strategy implementation and risk management decisions at Sydney IVF, a research-based in vitro fertilization and stem cell company based in Australia. Drs. Robert Jansen and Jock Anderson, who co-founded Sydney IVF in 1986, developed novel...
View Details
Keywords:
Ethics;
Governing Rules, Regulations, and Reforms;
Innovation and Management;
Growth and Development Strategy;
Risk Management;
Genetics;
Commercialization;
Health Industry;
Australia
Simons, Robert L., Kathryn Rosenberg, and Natalie Kindred. "Sydney IVF: Stem Cell Research." Harvard Business School Case 109-017, January 2009. (Revised February 2009.)
- November 2007
- Class Lecture
The Baby Business (FSS)
By: Debora L. Spar
In vitro fertilization and genetic screening are possible with the advent of biotechnology. International adoptions, surrogacy, and other approaches to family planning are on the rise. But few rules govern these measures, medical costs can be prohibitive, and...
View Details
Keywords:
Governing Rules, Regulations, and Reforms;
Policy;
Demand and Consumers;
Business and Government Relations;
Business and Stakeholder Relations;
Genetics;
Societal Protocols;
Commercialization;
Health Industry;
Health Industry
Spar, Debora L. "The Baby Business (FSS)." Harvard Business School Class Lecture 708-701, November 2007.
- January 2007 (Revised April 2011)
- Case
Farmacias Similares: Private and Public Health Care for the Base of the Pyramid in Mexico
By: Michael Chu and Regina Garcia-Cuellar
Farmacias Similares, serving Mexico's low-income sector, grew to $600 million sales and 3,400 drugstores while deep reforms to help the poor swept the public health system. Adjacent to each store, for $2 per visit, medical clinics provided access to doctors for 2.3...
View Details
Keywords:
Private Sector;
Public Sector;
Health Care and Treatment;
Growth and Development Strategy;
Poverty;
Pharmaceutical Industry;
Retail Industry;
Mexico
Chu, Michael, and Regina Garcia-Cuellar. "Farmacias Similares: Private and Public Health Care for the Base of the Pyramid in Mexico." Harvard Business School Case 307-092, January 2007. (Revised April 2011.)
- July 2005 (Revised December 2006)
- Case
Japan: Deficits, Demography, and Deflation
By 2005, Japan's debt had risen to 163% of GDP. For more than a decade, the government had run huge deficits, trying unsuccessfully to stimulate economic growth. Interest rates, meanwhile, had been zero for years. But with slow growth and banks in crisis, nothing had...
View Details
Keywords:
Economy;
Economic Growth;
Demographics;
Financial Condition;
Inflation and Deflation;
Banks and Banking;
Borrowing and Debt;
Macroeconomics;
Policy;
Government and Politics;
Welfare;
Health Care and Treatment;
Japan
Vietor, Richard H.K. "Japan: Deficits, Demography, and Deflation." Harvard Business School Case 706-004, July 2005. (Revised December 2006.)
- May 25, 2004
- Article
Specialization and Its Discontents: The Pernicious Impact of Regulations Against Specialization and Physician Ownership on the U.S. Healthcare System
Keywords:
Health Care and Treatment;
Ownership;
Governing Rules, Regulations, and Reforms;
Health Industry;
United States
Herzlinger, Regina E. "Specialization and Its Discontents: The Pernicious Impact of Regulations Against Specialization and Physician Ownership on the U.S. Healthcare System." Circulation 109, no. 20 (May 25, 2004): 2376–2378.
- October 2002 (Revised February 2006)
- Case
Codex Alimentarius and Food Labeling
By: Ray A. Goldberg and Hal Hogan
Codex Alimentarius is a set of international food standards devised by the Codex Commission, a body within the United Nations jointly sponsored by the FAO and WHO. The purpose of the standards is to harmonize global trade in food products and agricultural commodities,...
View Details
Keywords:
Standards;
Trade;
Agreements and Arrangements;
Food;
Agribusiness;
Governing Rules, Regulations, and Reforms;
Globalization;
Health;
Food and Beverage Industry;
Agriculture and Agribusiness Industry
Goldberg, Ray A., and Hal Hogan. "Codex Alimentarius and Food Labeling." Harvard Business School Case 903-417, October 2002. (Revised February 2006.)
- November 2001
- Case
Aventis CropScience and StarLink Corn
By: Ray A. Goldberg and James M Beagle
Aventis CropScience responds to the discovery of an unapproved corn variety in food supplies and draws lessons for the company, industry, and governments.
View Details
- August 2001
- Case
Scios, Inc.
Scios, filled with distinguished scientists and experienced managers, nevertheless fails to clear the FDA Phase III process for an important biotechnology drug. This case asks the students to analyze the social costs and benefits of the regulatory process.
View Details
- March 1999
- Case
Merck & Co., Inc.: Corporate Strategy, Organization and Culture (A)
By: Michael Beer and Perry Fagan
In the early 1990s, Merck faced a series of challenges because of significant changes in its competitive and regulatory environment (e.g., growth in power of pharmaceutical buyers like managed care organizations led to price pressures and President Clinton's review of...
View Details
Keywords:
Organizational Change and Adaptation;
Business or Company Management;
Organizational Culture;
Problems and Challenges;
Management Practices and Processes;
Competitive Strategy;
Management Teams;
Health Care and Treatment;
Governing Rules, Regulations, and Reforms;
Situation or Environment;
Alignment;
Pharmaceutical Industry;
United States
Beer, Michael, and Perry Fagan. "Merck & Co., Inc.: Corporate Strategy, Organization and Culture (A)." Harvard Business School Case 499-054, March 1999.
- October 1997 (Revised April 2002)
- Case
Planned Parenthood Federation of America (A)
By: V. Kasturi Rangan and Elaine V. Backman
Outlines the dynamic shifts in the external environment surrounding Planned Parenthood's operations in 1994. Health care reform was threatening some of its core customer base. The organization had to come up with a strategy and a process for adapting to the new...
View Details
Rangan, V. Kasturi, and Elaine V. Backman. "Planned Parenthood Federation of America (A)." Harvard Business School Case 598-001, October 1997. (Revised April 2002.)
- September 1991 (Revised February 1993)
- Case
Burroughs Wellcome and AZT (A)
Burroughs Wellcome Co., developer of AZT, the first drug approved by the U.S. Food and Drug Administration for the treatment of Acquired Immune Deficiency Syndrome (AIDS), finds itself under siege in September 1989 by AIDS activists and various segments of the U.S....
View Details
Keywords:
Governing Rules, Regulations, and Reforms;
Ethics;
Business and Government Relations;
Communication Strategy;
Health Care and Treatment;
Monopoly;
Intellectual Property;
Research and Development;
Price;
Pharmaceutical Industry;
London
Emmons, Willis M., III. "Burroughs Wellcome and AZT (A)." Harvard Business School Case 792-004, September 1991. (Revised February 1993.)
- Teaching Interest
Overview
By: Leemore S. Dafny
U.S. Healthcare Strategy
The U.S. healthcare sector accounts for 17 percent of GDP, and encompasses a diverse set of industries with public, nonprofit, and for-profit buyers and sellers. There are significant concerns about high and rising spending, and...
View Details
- Forthcoming
- Article
Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms
By: Caroline Marra and Ariel D. Stern
Digital health technologies (DHTs) can enable more patient-centric therapeutic development by generating evidence that captures how patients feel and function, enabling decentralized trial designs that increase participant inclusivity and convenience, and collecting...
View Details
Keywords:
Health Care and Treatment;
Technological Innovation;
Product Development;
Health Testing and Trials;
Governing Rules, Regulations, and Reforms
Marra, Caroline, and Ariel D. Stern. "Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms." Clinical Pharmacology & Therapeutics (forthcoming). (Pre-published online February 2, 2024.)
- ←
- 6